Middle East and Africa Nasal Drug Delivery Market Was Valued $ 1 Billion in 2015 and Is Expected to Witness a Robust CAGR of 8.1% with $ 1.59 Billion Growth in 2022
The Intra-Nasal route of drug administration is becoming popular due to its noninvasive nature thereby reducing pain and threat of infections and allows the patient to self-administer drugs without any help from anyone. Moreover recent research has also pointed its applications related to drug delivery to the brain. The Middle East and Africa Nasal Drug Delivery Market to reach around $ 1.59 billion in 2022 growing at a CAGR of 8.1%; this market was worth $ 1 billion in 2015.
View full press release